{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:15:29Z","timestamp":1762542929914,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cllc.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T12:05:51Z","timestamp":1535976351000},"page":"e29-e38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Moderately Hypofractionated Helical IMRT, FDG\u2013PET\/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-4390","authenticated-orcid":false,"given":"Andrei","family":"Fodor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Incerti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italo","family":"Dell\u2019Oca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Samanes Gajate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro G.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Passoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Gianolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Calandrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2018.08.019_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2018.08.019_bib2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"A\u00a0phase III study of permetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/030089161209800206","article-title":"Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006","volume":"98","author":"Barbieri","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.cllc.2018.08.019_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomized feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomized international, multicenter phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib7","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(16)00024-3","article-title":"Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?","volume":"17","author":"Rimner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2018.08.019_bib9","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00066-011-2234-6","article-title":"PET-guided dose escalation tomotherapy in malignant pleural mesothelioma","volume":"187","author":"Fodor","year":"2011","journal-title":"Strahlenther Onkol"},{"issue":"Suppl 1","key":"10.1016\/j.cllc.2018.08.019_bib11","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.lungcan.2005.03.007","article-title":"The role of PET in the surgical management of malignant pleural mesothelioma","volume":"49","author":"Flores","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.08.019_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2018.08.019_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A\u00a0phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2018.08.019_bib14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/JTO.0000000000000499","article-title":"Is radiotherapy useful for treating pain in mesothelioma? A phase II trial","volume":"10","author":"MacLeod","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2014.05.032","article-title":"Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma","volume":"90","author":"Rimner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","article-title":"Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and matched survival analysis","volume":"91","author":"Chance","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracicradiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"De Perrot","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2018.08.019_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.08.003","article-title":"The role of radical radiotherapy in the management of malignant pleural mesothelioma: a systematic review","volume":"125","author":"Ashton","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib20","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"De Perrot","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.rpor.2017.07.006","article-title":"Malignant pleural mesothelioma- pleural cavity irradiation after decortication with helical tomotherapy","volume":"22","author":"Harrabi","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.cllc.2018.08.019_bib22","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/JTO.0b013e318272601f","article-title":"Tomotherapy after pleurectomy\/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung","volume":"7","author":"Minatel","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2013.10.013","article-title":"Radical pleurectomy\/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up","volume":"83","author":"Minatel","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.08.019_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2015.06.029","article-title":"Radical radiation therapy after lung-sparing surgery for malignant pleural mesothelioma: survival, pattern of failure, and prognostic factors","volume":"93","author":"Minatel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.canrad.2017.05.007","article-title":"High dose irradiation after pleurectomy\/decortication or biopsy for pleural mesothelioma treatment","volume":"21","author":"Parisi","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.cllc.2018.08.019_bib26","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.prro.2014.11.005","article-title":"Early experience with intensity modulated proton therapy for lung-intact mesothelioma: a case series","volume":"5","author":"Pan","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib27","first-page":"e1705","article-title":"Proton therapy for malignant pleural mesothelioma: a three cases series describing the clinical and dosimetric advantages of proton-based therapy","volume":"9","author":"Lee","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.cllc.2018.08.019_bib28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijrobp.2009.11.006","article-title":"Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy","volume":"78","author":"Krayenbuehl","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.08.019_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00066-017-1108-y","article-title":"Dose selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? A planning study","volume":"193","author":"Botticella","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.cllc.2018.08.019_bib30","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S1470-2045(18)30100-1","article-title":"Novel therapies for malignant pleural mesothelioma","volume":"19","author":"Scherpereel","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.08.019_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00066-015-0901-8","article-title":"Tomotherapy PET- guided dose escalation: a dosimetric study for patients with malignant pleural mesothelioma","volume":"192","author":"Maggio","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.cllc.2018.08.019_bib32","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes. A population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cllc.2018.08.019_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1378\/chest.07-0554","article-title":"Long-term survival following pneumonectomy for non-small cell lung cancer","volume":"132","author":"Kim","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2018.08.019_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2018.08.019_bib35","doi-asserted-by":"crossref","first-page":"j413","DOI":"10.1136\/bmj.j413","article-title":"Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up","volume":"356","author":"Eurich","year":"2017","journal-title":"BMJ"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418302328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418302328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:08:09Z","timestamp":1761505689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730418302328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1525730418302328"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2018.08.019","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderately Hypofractionated Helical IMRT, FDG\u2013PET\/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}